This Award Notice opportunity from Department Of Defense was posted on August 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

PHENYLEPHRINE HYDROCHLORIDE INJECTION

Awarded

SPE2DP26F9275Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

Solicitation # SPE2DP-27-T-0284

Solicitation SPE2DP-27-T-0284 is for the procurement of Zinc Oxide Ointment (NSN 6505001501990), a topical skin protectant containing 20% zinc oxide. The product must meet USP standards and be supplied in collapsible tubes, with each unit of issue consisting of a 28.35gm (1oz) tube. The procurement is divided into multiple line items, including CLIN 0001 for 6 units, CLIN 0002 for 4 units, and CLIN 0004 for 5 units. The ointment must be stored at a controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months. The contract requires delivery FOB Destination to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with a delivery window of 5 days and required delivery dates in November 2026. Packaging must adhere to DLA requirements, with hazardous materials following TQ requirement IP025 and non-hazardous materials following ASTM D3951. All shipments must be sent via the fastest traceable means, as parcel post is prohibited. The contract incorporates various FAR and DFARS clauses, including requirements for cybersecurity reporting, the Buy American Act, and FDA regulation compliance. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0273

Solicitation SPE2DP-27-T-0273 is a fixed-price, small business set-aside procurement for Famotidine Tablets, 20 MG, in unit dose 100s. The requirement is for four packages, with each package containing 100 tablets, under NSN 6505013104178. This FDA-regulated drug must be delivered FOB Destination to the Medical Company in Worcester, Massachusetts, with a required delivery date of November 12, 2026, and a delivery lead time of five days. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contractor must adhere to strict packaging and marking standards, utilizing commercial packaging and ensuring each unit is in a sealed container to prevent damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item is subject to a non-extendable shelf-life requirement of 30 months. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment, compliance with the Buy American and Balance of Payments Program, and adherence to DFARS cybersecurity and hazardous material labeling regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-27-T-1624

Solicitation SPE2DS-27-T-1624 is for the procurement of medical test strips and color charts (NSN 6550-01-221-5400) used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in urine. The requirement consists of three line items, each for one bottle containing 100 strips. Delivery is required within 20 days after order, with destination points at Fort Campbell, Kentucky, and the USNS Charles Drew. The items are subject to a non-extendable shelf life of 18 months, with a requirement that no more than two months elapse between the date of manufacture and the date of delivery to the government. Packaging must be commercial and compliant with ASTM D3951 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. The contract incorporates several critical regulatory clauses, including the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 regarding the safeguarding of covered defense information. Payment and receiving reports must be processed electronically via the Wide Area WorkFlow system. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

OMEPRAZOLE EXTENDED-RE

Solicitation # SPE2DP-27-T-0286

Solicitation SPE2DP-27-T-0286 is a procurement for Omeprazole Extended-Release Capsules, 20 mg, in quantities of 30 per unit. The contract consists of two line items, each for 4 bottles, with a required delivery date of November 13, 2026. The items must be stored at USP controlled room temperature between 20 and 25 degrees Celsius and have a non-extendable shelf life of 18 months. Delivery is FOB Destination, with inspection and acceptance occurring at the destination points in Worcester, Massachusetts, and Fort Lewis, Washington. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. All items must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for destination inspection, safeguarding covered defense information, and the use of the Wide Area Workflow system for electronic invoicing. All quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0287

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-27-T-0276

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0282

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0272

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

IBUPROFEN ORAL SUSPENS

Solicitation # SPE2DP-27-T-0285

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

LEVONORGESTREL AND ETH

Solicitation # SPE2DP-27-T-0283

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0281

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-27-T-0277

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

10 minutes ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency Troop Support Medical Supply Chain awarded delivery order SPE2DP26F9275 to DMS Pharmaceutical Group Inc on August 28, 2026. This order, issued under the base administrative contract SPE2DX25D9900 and NAICS code 325412, is designated as a Women-Owned Small Business set-aside. The contract is for the procurement of Phenylephrine Hydrochloride Injection, identified by NSN 6505001049320. The total contract price is 58.56 for a quantity of 248 boxes at a unit price of 19.52. The specified place of delivery for these medical supplies is Fort Bragg, North Carolina. This action follows the establishment of the base admin contract which replaced previous agreements to streamline the supply chain for the Department of Defense.

General Info

DMS Pharmaceutical Group will supply Phenylephrine Hydrochloride Injection to Fort Bragg for 58.56.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$58.56

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

WOSB

Awardee

DMS PHARMACEUTICAL GROUP INC

Award Issued Date

08/28/2026, 12:00:00 AM UTC

Documents

award

High

task-order-award

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 28

Award Notice

AwardedAug 28

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2DP26F9275 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $58.56 Award Date: 08-28-2026 Delivery order under: SPE2DX25D9900 Line items: - PHENYLEPHRINE HYDROCHLORIDE INJECTION (NSN/Part 6505001049320, PR 7018111687)